Capricor Therapeutics (CAPR) Asset Utilization Ratio (2012 - 2025)
Capricor Therapeutics (CAPR) posted quarterly Asset Utilization Ratio of 0.09 for Q3 2025, down 80.16% year-over-year from 0.43 in Q3 2024, and down 8.15% quarter-over-quarter from 0.09 in Q2 2025.
Capricor Therapeutics (CAPR) Asset Utilization Ratio (2012 - 2025) Analysis & Trends
Capricor Therapeutics' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.09 for Q3 2025.
- In Q3 2025, Asset Utilization Ratio fell 80.16% year-over-year to 0.09; the TTM figure through Sep 2025 stood at 0.09 (down 80.16% YoY), while the FY2024 annual figure was 0.19, down 58.0% from the prior year.
- Asset Utilization Ratio for Q3 2025 stood at 0.09, down from 0.09 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.74 in Q2 2024, with the low at 0.0 in Q1 2021.
- The 5-year median for Asset Utilization Ratio is 0.11 (2023), against an average of 0.21.
- The sharpest annual moves came in 2021 and 2023: Asset Utilization Ratio slumped 94.4% in 2021, then jumped 970.54% in 2023.
- Capricor Therapeutics' Asset Utilization Ratio stood at 0.01 in 2021, then soared by 745.62% to 0.05 in 2022, then surged by 970.54% to 0.53 in 2023, then slumped by 60.44% to 0.21 in 2024, then sank by 58.79% to 0.09 in 2025.
- Business Quant data shows CAPR's Asset Utilization Ratio at 0.09 in Q3 2025, 0.09 in Q2 2025, and 0.11 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.09 |
| Jun 30, 2025 | 0.09 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.43 |
| Jun 30, 2024 | 0.74 |
| Mar 31, 2024 | 0.60 |
| Dec 31, 2023 | 0.53 |
| Sep 30, 2023 | 0.34 |
| Jun 30, 2023 | 0.19 |
| Mar 31, 2023 | 0.11 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 0.03 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.01 |
| Sep 30, 2020 | 0.01 |
| Jun 30, 2020 | 0.02 |